Axsome Therapeutics Inc (STU:19X)
€ 81.28 -1.42 (-1.74%) Market Cap: 3.94 Bil Enterprise Value: 3.83 Bil PE Ratio: 0 PB Ratio: 40.50 GF Score: 36/100

Axsome Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 05, 2020 / 01:00PM GMT
Release Date Price: €65.44 (-0.58%)
Operator

Good morning, ladies and gentlemen, and welcome to the Axsome Therapeutics Conference Call. (Operator Instructions) And as a reminder, today's conference call is being recorded. (Operator Instructions) I would now like to turn the conference over to your host, Herriot Tabuteau, Chief Executive Officer. Please go ahead.

Herriot Tabuteau
Axsome Therapeutics, Inc. - Founder, Chairman, CEO & President

Good morning. I am Herriot Tabuteau, Chairman and Chief Executive Officer of the company. Will the meeting please come to order?

Now let me take this opportunity to welcome everyone to the 2020 Annual Meeting of Stockholders of Axsome Therapeutics. Due to the continued public health concerns resulting from the COVID-19 pandemic and government recommended and required limits on public gatherings and to protect the health and safety of the company's stockholders, directors and employees, this year's annual meeting is being held in a virtual-only meeting format. This allows stockholders, regardless of physical location, to participate in today's meeting.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot